422 related articles for article (PubMed ID: 24985407)
1. Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.
Gandini S; Puntoni M; Heckman-Stoddard BM; Dunn BK; Ford L; DeCensi A; Szabo E
Cancer Prev Res (Phila); 2014 Sep; 7(9):867-85. PubMed ID: 24985407
[TBL] [Abstract][Full Text] [Related]
2. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.
Decensi A; Puntoni M; Goodwin P; Cazzaniga M; Gennari A; Bonanni B; Gandini S
Cancer Prev Res (Phila); 2010 Nov; 3(11):1451-61. PubMed ID: 20947488
[TBL] [Abstract][Full Text] [Related]
3. Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis.
Noto H; Goto A; Tsujimoto T; Noda M
PLoS One; 2012; 7(3):e33411. PubMed ID: 22448244
[TBL] [Abstract][Full Text] [Related]
4. Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis.
Tang GH; Satkunam M; Pond GR; Steinberg GR; Blandino G; Schünemann HJ; Muti P
Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):627-635. PubMed ID: 29618465
[No Abstract] [Full Text] [Related]
5. Association of metformin use with cancer incidence and mortality: a meta-analysis.
Zhang P; Li H; Tan X; Chen L; Wang S
Cancer Epidemiol; 2013 Jun; 37(3):207-18. PubMed ID: 23352629
[TBL] [Abstract][Full Text] [Related]
6. Metformin and breast cancer risk: a meta-analysis and critical literature review.
Col NF; Ochs L; Springmann V; Aragaki AK; Chlebowski RT
Breast Cancer Res Treat; 2012 Oct; 135(3):639-46. PubMed ID: 22847511
[TBL] [Abstract][Full Text] [Related]
7. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
[TBL] [Abstract][Full Text] [Related]
8. The effect of metformin on mortality following cancer among patients with diabetes.
Lega IC; Shah PS; Margel D; Beyene J; Rochon PA; Lipscombe LL
Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1974-84. PubMed ID: 25030683
[TBL] [Abstract][Full Text] [Related]
9. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
[TBL] [Abstract][Full Text] [Related]
10. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis.
He XK; Su TT; Si JM; Sun LM
Medicine (Baltimore); 2016 Feb; 95(7):e2749. PubMed ID: 26886616
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies.
Pladevall M; Riera-Guardia N; Margulis AV; Varas-Lorenzo C; Calingaert B; Perez-Gutthann S
BMC Cardiovasc Disord; 2016 Jan; 16():14. PubMed ID: 26769243
[TBL] [Abstract][Full Text] [Related]
12. Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus.
Perez-Lopez FR; Pasupuleti V; Gianuzzi X; Palma-Ardiles G; Hernandez-Fernandez W; Hernandez AV
Maturitas; 2017 Jul; 101():6-11. PubMed ID: 28539171
[TBL] [Abstract][Full Text] [Related]
13. Metformin Use and Lung Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis.
Yao L; Liu M; Huang Y; Wu K; Huang X; Zhao Y; He W; Zhang R
Dis Markers; 2019; 2019():6230162. PubMed ID: 30881522
[TBL] [Abstract][Full Text] [Related]
14. Metformin and thyroid carcinoma incidence and prognosis: A systematic review and meta-analysis.
Wang Z; Luo J; Zhang Y; Xun P; Chen Z
PLoS One; 2022; 17(7):e0271038. PubMed ID: 35901016
[TBL] [Abstract][Full Text] [Related]
15. Antidiabetic Medications and the Risk of Endometrial Cancer in Patients.
Tian J; Liang Y; Qu P
Gynecol Obstet Invest; 2019; 84(5):455-462. PubMed ID: 30808843
[TBL] [Abstract][Full Text] [Related]
16. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
Hu J; Chen JB; Cui Y; Zhu YW; Ren WB; Zhou X; Liu LF; Chen HQ; Zu XB
Medicine (Baltimore); 2018 Jul; 97(30):e11596. PubMed ID: 30045293
[TBL] [Abstract][Full Text] [Related]
17. The relationship between the use of metformin and the risk of pancreatic cancer in patients with diabetes: a systematic review and meta-analysis.
Hu J; Fan HD; Gong JP; Mao QS
BMC Gastroenterol; 2023 Feb; 23(1):50. PubMed ID: 36829129
[TBL] [Abstract][Full Text] [Related]
18. Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis.
Han Y; Xie H; Liu Y; Gao P; Yang X; Shen Z
Cardiovasc Diabetol; 2019 Jul; 18(1):96. PubMed ID: 31362743
[TBL] [Abstract][Full Text] [Related]
19. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.
Ma SJ; Zheng YX; Zhou PC; Xiao YN; Tan HZ
Oncotarget; 2016 Oct; 7(40):66202-66211. PubMed ID: 27494848
[TBL] [Abstract][Full Text] [Related]
20. Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.
Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
Am J Gastroenterol; 2013 Jun; 108(6):881-91; quiz 892. PubMed ID: 23381014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]